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Abstract
Background: The GLI transcription factors, mediators of the hedgehog signal bind with high affinity to the
consensus sequence GACCACCCA. The affinity of variant single substitutions in GLI binding sites has been
measured systematically, but the affinities of the variant binding sites appears low compared to the frequency of
occurrence of variant sites in known GLI target gene promoters.
Results: We quantified transcriptional activation by GLI using PTCH1 promoter based luciferase reporters containing
all single substitutions of the GLI consensus binding site. As expected variants with very low affinity did not
activate the reporter. Many lower affinity binding sequences are, however, functional in the presence of moderate
GLI concentration. Using two natural non-consensus GLI site promoters we showed that substitution of the variant
sequences by consensus leads to comparable activity.
Conclusions: Variant GLI binding sites with relatively low affinity can within natural promoters lead to strong
transcriptional activation. This may facilitate the identification of additional direct GLI target genes.
Background
Sequence specific binding of transcription factors in
response to diverse cellular input signals is a major
determinant in the regulation of transcription. Binding
sequences for many factors have been identified by
experiment and/or by a wealth of prediction methods
(reviewed in [1]). Consensus binding sites were classi-
cally determined by SELEX experiments and verified by
EMSA while more recently affinity measurements by
methods better suited to moderate to large scale experi-
mentation like microarray binding experiments have
been used [2]. Experimentally determined affinities or
frequencies for each base at every position of a binding
site can be represented as position weight matrices or
sequence logos, which can be used for prediction of new
binding sites [3,4]. It is well known that not all
sequences, which a transcription factor strongly binds to
in vitro will also be bound in an in vivo context [5].
Global chromatin immunoprecipitation can identify the
sequences bound by a transcription factor within the
cellular context but does not indicate whether the
binding site is functional, i.e. whether the presence of a
given TF at this site affects expression of the target
gene. For this, additional information usually derived
from microarray data, sequencing or promoter studies is
required [6,7].
Relative binding affinity is a good indicator of tran-
scriptional activation or repression in an artificial system
as shown for example by Kang et al for the Zif268 DNA
binding domain joined to repressor or activator domains
[8]. A detailed description of the quantitative relation-
ship between affinity and activation potential in the cell
is difficult since in vivo activation depends on the pre-
sence of co-factors, additional transcription factors and
the epigenetic state of the chromatin. On the other
hand, a single high affinity binding site in combination
with a minimal promoter frequently does not produce
strong target gene activation and reporter constructs
therefore usually contain several repeats of consensus
binding sites to enhance reporter activity. In the analysis
of specific promoters attention is usually first focussed
on consensus sites though the functionality of variant
sites for many transcription factors has been shown in
vivo and in reporter gene assays. The effect of variation
in a single site on activation and specificity has
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mammalian promoters the influence of variant sites on
transcriptional activation has not been explored
systematically.
The three GLI transcription factors, mediators of the
hedgehog signal, comprise a DNA binding domain of
five zinc fingers, which are very highly homologous in
the three GLIs. Two of the five fingers are responsible
for all but one of the protein-DNA base contacts [10].
The GLIs can function as activators and/or repressors
and regulate target genes in a highly context specific
way. The consensus binding sequence GACCACCCA
was first determined by Kinzler et al [11] and many
direct GLI target genes have been identified. Hallikas et
al [12] determined the affinities of all single base substi-
tutions in the GLI consensus binding sequence using a
fusion of luciferase with the GLI-DNA binding domain
in an in vitro assay. These data together with informa-
tion on species conservation were used in the novel EEL
prediction program to identify GLI regulated genes
within the mouse and human genome. These predic-
tions were successful in identifying new target genes
though some known target genes were not represented
in the original version. This emphasizes the need to
characterise in more detail the relationship between affi-
nity and functionality of GLI binding sites in functional
assays.
We therefore set out to investigate the activity of all
single site variants of the consensus GLI binding site in
a luciferase assay. Frequently GLI transcriptional activity
is measured in an artificial construct containing multiple
copies of the consensus site. Here we use a construct
based on the PTCH1 promoter, which is functional in
many different cell types and should approximate a
“normal” control of gene expression. Using relatively
low GLI concentration to enhance specificity we found
that a rather large number of variant GLI binding sites
was able to activate transcription within the PTCH1
promoter. We then proceeded to turn variant binding
sites into consensus within two unrelated natural pro-
moters containing essential non-consensus GLI binding
sites and found that activity was not significantly
enhanced.
Results and Discussion
A PTCH1 reporter system to measure the functionality of
variant GLI binding sites
The hedgehog receptor PTCH1 is a well characterised
direct GLI target gene and its elevated expression is
indicative of Hh pathway activation. PTCH1 expression
is driven from several alternative transcription start sites
[13]. The PTCH1 promoter region upstream of exon 1B
(Figure 1A) has been shown to contain a GLI consensus
site (BS2, -704) [14] essential for activation by GLI. We
localised a second GLI binding site (BS1,
G A C C T C C C A )w i t has i n g l es u b s t i t u t i o nc o m p a r e dt o
consensus upstream of BS2 at -1033. The presence of
BS1 only is not sufficient for promoter activation by
GLI in a luciferase assay, but it enhances transcriptional
activation in the presence of BS2 (Figure 1C). We chose
to use the essential BS2 site in the PTCH1 promoter to
investigate the influence of all 27 possible single base
substitutions in the consensus sequence on transcrip-
tional activation. To facilitate the exchange of consensus
by the variant binding site we replaced the consensus
site with a linker sequence permitting the test sequence
to be quickly inserted into the PTCH1 luciferase repor-
ter construct (PTCH1_VAR) (Figure 1A). Together with
the variant sequence, a HindIII site was inserted to
allow fast identification of plasmids containing the var-
iant sequence. The base C in position 14 relative to the
start of the consensus sequence has previously been
shown to positively affect GLI binding affinity [12,15]
a n di si n c l u d e di nt h ec o n s t r u c ta sp a r to ft h eHindIII
site.
We then tested the functionality of the luciferase
reporter system by comparing the ability of GLI2act to
activate the reporter constructs containing the linker
with the consensus sequence (PTCH1_VAR_(cons)) to
the unmodified PTCH1 promoter luciferase reporter
construct (PTCH1_WT) (Figure 1B). All results pre-
sented here were obtained with GLI2act, which is a
strong activator. When GLI1 was used comparable
results were obtained though activity was lower (data
n o ts h o w n ,C Su n p u b l i s h e d ) .A ss h o w ni nF i g u r e1 B
both wild type (PTCH1_WT) and modified PTCH1 pro-
moter construct (PTCH1_VAR(Cons)) were strongly
induced in response to GLI2act with only slightly lower
activation for the modified PTCH1 promoter (Figure
1B). As expected, the inactive variant 6G7G (GAC-
CAGGCA) (Figure 1B) in PTCH1_WT as well as in
PTCH1_VAR resulted in strongly reduced reporter
activity. No activation was observed with PTCH1_VAR,
with no inserted sequence. Thus, the modified PTCH1
reporter system is functional and can be used to system-
atically measure the effect of variation in GLI binding
sequence on GLI target gene activation.
The effect of GLI binding site variants on PTCH1
promoter activation
To determine GLI activity for all single site variants of
the 9 bp consensus binding sequence we co-transfected
each PTCH1_VAR luciferase reporter together with
GLI2act into HaCaT cells (Figure 2A). As a negative
control we used PTCH1_VAR(6G7G) (Figure 1B). To
exploit the dynamic range of the reporter system, all
assays were performed under optimal transcriptional
activation conditions using moderate GLI2act levels.
The boxplot (Figure 2A) shows the range of activities
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pared to negative control and to consensus is shown in
Figure 2B. At first view it is striking that many sequence
variants result in reporter activation similar to the con-
sensus GLI binding site. Especially in position 5 there is
no significant difference in the transcriptional activities
between consensus and any non-consensus bases (Figure
2A, B). In contrast, any substitution in position 4 or 6
leads to loss of activity, consistent with affinity measure-
ments showing complete loss of GLI binding if these
critical positions are altered (CS unpublished). There are
several positions where the identity of the substituted
base shows a pronounced effect on transcriptional acti-
vation: in position 7 (C in consensus), G and T do not
lead to reporter gene transcription while A reproducibly
equals or even appears to exceed the level of activation
by consensus. A number of variants results in activities
intermediate between consensus and background. Tak-
ing into account the variability inherent in biological
replicates it is not possible to attach significance to rela-
tively small differences in activity. To exclude the possi-
bility that the linker sequence, which surrounds the
binding site differentially affects the activation of the
various reporter constructs, we also tested a small num-
ber of binding site variants directly within the unmodi-
fied PTCH1 promoter construct by introducing site-
specific mutations (Figure 3). No major discrepancies
were observed, suggesting in summary that many variant
GLI binding sites are functional and can substitute for
the consensus. We then compared the transcriptional
activation (Figure 2A) to the affinity profile described by
Hallikas et al [12] and found that a large number of
substitutions, which have quite low affinity significantly
activate the luciferase reporter. This may be due to the
fact that the nonlinear normalization applied to the raw
data very strongly emphasizes the consensus site [16].
Conventional competitive EMSA measurements on
selected binding sequences with linear normalization
Figure 1 PTCH1 reporter constructs. (A) For PTCH1_WT a 1.3 kb fragment (-1022 to +211 relative to the main TSS) was cloned upstream of
the firefly luciferase gene of the pGL3b vector. GLI binding sites BS1 and BS2 are represented by boxes, arrowheads indicate the orientation of
the binding site. For PTCH1_VAR, binding site BS2 was replaced by a 29 bp linker. All variant GLI binding sites were inserted between the NsiI
and XhoI restriction sites of the linker (consensus sequence is shown). (B) PTCH1_WT and PTCH1_VAR luciferase reporters with the GLI consensus
binding site were co-transfected with GLI2act expression vector into HaCaT cells. Variants 6G7G (G in position 6 and 7 of consensus) were used
as inactive controls. PTCH1_WT and PTCH1_VAR(Cons) show comparable activation, no activation was observed for 6G7G and the empty
PTCH1_VAR construct. (C) BS2 is absolutely required for activation of the PTCH1 wild type promoter PTCH1_WT. PTCH1_WT or mutagenized
variants (mBS1, mBS2) were cotransfected with GLI2act into HaCaT cells. Mutagenesis of BS2 (GACCACCCA) to 6G7G completely abolishes
activation of the PTCH1_WT reporter construct (mBS2), while substitution of BS1 (GACCTCCCA) with 6G7G only reduces the luciferase signal
(mBS1).
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within a factor of 10 of the consensus (CS, unpublished),
which are compatible with the results of the luciferase
reporter activity found. This is also consistent with the
e x i s t e n c eo fm a n ys i n g l ea n ds e v e r a ld o u b l es u b s t i t u -
tions in the GLI consensus sequence of promoters with
known GLI dependent function in vivo (Table 1), which
failed to be retrieved in genome-wide in silico searches
for GLI target genes [12] e.g. BCL2, IL1R2, FST, TGM3
(Table 1).
Though not perfectly representing the context of
chromatin, luciferase reporter assays can be used to dis-
tinguish between potentially functional GLI binding sites
and apparent binding sites, which do not activate repor-
ter gene activity within their sequence context. This can
be demonstrated clearly for the TGM3 promoter, which
Figure 2 Luciferase reporter activation by single site variants. (A) HaCaT cells were co-transfected in triplicate with GLI2act expression
constructs and the PTCH1_VAR luciferase reporter containing the consensus or a single site variant or the 6G7G (negative control). LacZ
expression plasmid was added for normalization to all transfections. RLU for each transfection were first normalized with respect to lacZ
expression and then with respect to the mean of RLU of three consensus samples from the same 24 well plate. The boxplot represents the
results of two independent experiments normalized separately and then pooled to result in 6 measurements per position and base. Boxplots
indicate the range (whiskers), estimated lower and upper quartile (box) and median (line) of the normalized values, which are expressed as
percent of consensus activity. The consensus sequence in each position is coloured red and the corresponding base marked with an asterisk. A
statistical analysis using an exact Kruskal-Wallis test rejects the null-hypothesis of equal population medians at significance levels p < 0.01% (that
is, highly significant) for all positions with the exception of position 5, for which p = 46%. (B) Wilcoxon rank sum tests were done comparing the
values of the base in each position to the negative control 6G7G (left panel) and to the consensus site (right panel). On the left, the consensus
is highlighted by asterisks, on the right, the consensus positions have been left empty. p-values below 0.01 (1%) indicate clear rejections of the
null-hypothesis of the medians of the distributions being equal. There are only 4 non significant values on the left, among them no single
consensus. The right panel supports the boxplots in (A). Note, that due to the small sample size, only few numerical values are possible in all the
(exact) Wilcoxon tests.
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sus sequence and two variants with a C to A substitu-
tion in position 7 (7A) (Figure 4). Mutation of the
consensus sequence to nonbinding 6G7G does not affect
reporter activity nor is the consensus site bound by GLI
in a ChIP experiment (Figure 4B, C). In contrast, the
variant sites are bound by GLI and mutation of either
variant site abolishes transcriptional activation (Figure
4B, C).
Non-consensus GLI binding sites in GLI target gene
promoters
To further explore the influence of binding affinity on
transcriptional activation in a natural promoter context
other than PTCH1 we chose the JUN and GLI1 promo-
ters, both containing functional non-consensus GLI
binding sites, for further analysis
The human JUN (JUNpromWT2G5C) [17] and
human proximal GLI1 promoter (GLI1prom WT9G)
Figure 3 Validation of the transcriptional activation obtained with the PTCH1_VAR construct containing a selection of different
binding site variants with a modified PTCH1_WT construct in a luciferase assay. GLI binding site variations (3T, 8A, 6G7G) were introduced
into the PTCH_WT construct by site directed mutagenesis. HaCaT cells were co-transfected with the indicated reporter constructs and a GLI2act
expression construct together with LacZ for normalization. No significant differences were observed between the mutated PTCH_WT construct
and the PTCH_VAR construct demonstrating the relevance of the PTCH_VAR test system. 6G7G was used as inactive negative control.
Table 1 Functional non-consensus GLI binding sites in Hh target gene promoters
Gene/Promoter Binding site variant Number of substitutions Reference
Gli1 9G 1 [18]
TGM3 7A 1 [17]
FST Bs1 3A 1 [22]
Bs3 5G 1
BCL2 Bs3 2G 1 [21]
IL2R2 Bs1 3T 1 [23]
Bs2 1T2G 2
Bs3 1C9G 1
JUN Bs3 2G5C 2 [17]
BMP2 1C8A 2 [24]
HNF3b 3A 1 [25]
Fgf15 5T 1 [26]
Fgf15 Bs1 1T2G9G 3 [27]
Bs2 1T2G9T 3
CD155 2C 1 [28]
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thus eliminating possible interactions between nearby
GLI binding sites (Figure 5A, B). Either binding site var-
iant has been shown to be essential for activation by
GLI and both have significantly lower affinity than the
consensus site (9G coefficient according to Hallikas et al
binding profile 0.004 for GLI1 (0.982 for consensus) and
GLI3 (0.937 for consensus), 0.000 for GLI2 (0.982 for
consensus) (see Table S1 in [12]), double substitutions
as found in the JUN promoter were not tested under
identical conditions, [12,17]. To compare the activity of
the variants to the consensus, we applied site directed
mutagenesis to change the wild type variant sites to the
consensus sequence (GLI1promCons, JUNpromCons)
(Figure 5). The luciferase reporter constructs (GLI1-
promCons, JUNpromCons) were then tested for the
response to GLI2act in HaCaT cells and luciferase activ-
ity was compared to the respective wild type promoter
constructs (GLI1promWT9G, JUNpromWT2G5C). We
detected no significant difference between GLI consen-
sus and non consensus wild type sequences in the con-
text of either promoter. These results indicate that
relatively low binding site affinity does not prevent acti-
vation by GLI in a luciferase assay at optimal GLI
concentration.
Recent observations show that lower affinity binding
sites for transcription factors can be identified by glo-
bal ChIP [7] and occur quite frequently. Large scale
affinity measurements as described in [2] showed that
a large selection of transcription factors recognises
many variations of the primary motifs and that even
secondary motifs exist, which may possibly affect
changes in transcriptional specificity. A visible influ-
ence of low affinity sites on gene expression in yeast
has been described pointing to their potential rele-
vance for modulating gene expression [19]. Vokes et al
[15] identified a number of GLI promoters/enhancers,
which behave in a tissue specific way and are influ-
enced by nuclear GLI concentration. In a more global
study, groups of sites with high and lower affinities to
REST repressor were shown to cluster into groups
responsible for activation of target genes expressed
commonly, specifically or uniquely in different cell
lines [20]. These data imply an important role for
lower affinity sites in the context dependent control of
transcription and point to the need for more detailed
investigation of their function.
Conclusion
The results presented here specifically focus on the
activation potential of binding sites of the GLI tran-
scription factors, the mediators of the hedgehog signal.
We measured activation in a standardised luciferase
assay in the context of the PTCH1 promoter testing all
Figure 4 Activation of TGM3 in response to GLI requires two
low affinity GLI binding sites. (A) The human TGM3 upstream
regulatory region contains two non-consensus GLI binding sites (7A)
(BS2, BS3). Lines below represent DNA amplified by qPCR in ChIP (*;,
*;*;). (B) Luciferase reporter assay with the wild type TGM3 promoter
fragment (TGM3prom) and constructs with mutated putative GLI
binding sites (BS1 Mut, BS2 Mut, BS3 Mut). HaCaT cells were co-
transfected with promoter constructs as indicated and GLI2act
expression constructs or the empty expression vector pcDNA4/to.
Data shown are mean values of relative light units (RLU) of three
independent experiments. Mutation of either BS2 or BS3 completely
abolishes reporter activation while mutation of the consensus
sequence has no effect. (C) Chromatin immunoprecipitation (ChIP)
demonstrates specific binding of GLI2act to a region of the TGM3
promoter containing BS2 and BS3 (*;*; in A). No amplification was
observed for the region containing BS1, the GLI consensus binding
site (*; in A). Chromatin isolated from GLI2actHaCaT cells was
precipitated with either specific antibody (GLI2 N-20) or species
matched normal IgG (nIgG). As positive control the region of the
human PTCH promoter containing the functional consensus site
(PTCH BS2) was used. Data shown are fold enrichment of
specifically precipitated DNA (GLI2 N-20) compared to samples
using species matched normal IgG for unspecific precipitation.
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sequence. A rather large number of substitutions was
shown to be active, which is consistent with the exis-
tence of many known GLI target gene promoters con-
taining variant sites with lower binding affinity. Taking
into account the contribution of a larger subset of
binding sites with significant affinity the results pre-
sented in this study are likely to be helpful in the pre-
diction and experimental validation of more direct GLI
target genes.
Methods
Cloning
Numbering of base positions was according to [14] for
the PTCH1 promoter, to [17] for the JUN promoter and
to [18] for the GLI1 promoter. The GLI consensus site
orientation used is 5’GACCACCCA3’ [11]. The wild
type PTCH1 promoter (-1022 to +211) was amplified
from BAC #RP11/43505 (obtained from Children’s Hos-
pital Oakland Research Institute (CHORI)) and cloned
into the NheI and BglII sites of pGL3 basic vector (Pro-
m e g a ,M a d i s o n ,U S A ) .F o rt h eP T C H 1 _ V A Rc o n s t r u c t
GLI binding site BS2 (-704) was replaced with a 29 bp
linker sequence containing the restriction sites NsiI and
XhoI. Oligonucleotides representing all variant GLI
binding sites and including a HindIII restriction site for
quick screening of positive clones were inserted into the
pGL3_PTCH1_linker construct. (Figure 1A). To mutate
GLI binding sites in wild type promoters we used
QuickChange site-directed mutagenesis kit (Stratagene,
La Jolla, USA) according to the manufacturer’s protocol
and verified changes by sequencing. For primers and oli-
gos see Table 2.
Cell culture, transfection and luciferase reporter assays
HaCaT cells and GLI2actHaCaT [21] were cultured in
Dulbecco’s modified Eagle medium (high glucose, PAA,
Pasching, Austria) with 10% fetal calf serum (PAA,
Pasching, Austria) supplemented with streptomycin/
penicillin (Pen/Strep100x stock solution, PAA, Pasching,
Austria) at 37°C, 5% CO2. Cells were grown to 80% con-
fluence in 24-well plates and transfected in triplicate
with the pGL3 luciferase reporter plasmids, the GLI2act
expression (80 ng/transaction sample) construct [21] or
pcDNA4/TO as negative control using Superfect Trans-
fection reagent (Quiagen Inc., Valencia, CA). LacZ
expression plasmid (400 ng/transfection sample) was
used for normalization of transfection efficiency. Cells
were harvested 48 h after transfection, and luciferase
Figure 5 Changing functional non-consensus sites to consensus sites in selected GLI target gene promoters does not enhance
transcription. Wild type or mutated luciferase reporter constructs were co-transfected into HaCaT cells with GLI2act expression construct or
empty expression vector (pcDNA4/to) as control. (A) The human wild type JUN promoter (JUNprom_WT, upper panel) contains a functional
binding site with two substitutions compared to the GLI consensus sequence (2G5C) (upper panel). The GLI consensus sequence, when
introduced into this site (JUNprom_CONS), showed comparable reporter gene activation to the variant 2G5C. (B) The human GLI1 promoter
contains a functional binding site with the variant nucleotide G at position 9 (GLIprom_WT, upper panel). Introduction of the consensus
sequence at this position led to slightly higher activation in response to GLI2act than the wild type sequence.
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Labtec, Cambridge, UK) using Luciferase Assay Sub-
strate (Promega, Madison, USA).
Chromatin immunoprecipitation
ChIP from GLI2actHaCaT was done as described in
[22]. Antibodies used were: polyclonal goat-anti-GLI2
(GLI2-N20) (Santa Cruz Biotechnology) for specific pre-
cipitation and species matched normal IgGs (Santa Cruz
Biotechnology) for unspecific control. PCR primer
sequences are listed in Table 2.
Abbreviations
EMSA: Electrophoretic Mobility Shift Assay; TSS: Transcription Start Site;
SELEX: Systematic Evolution of Ligands by Exponential Enrichment; TF:
Transcription Factor; ChIP: Chromatin immunoprecipitation; Hh: Hedgehog;
RLU: Relative Light Unit.
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Table 2 Sequences of oligonucleotides used for cloning, site directed mutagenesis and ChIP
Usage Primer Sequence (5’-3’)
PTCH1_WT cloning
Prom_PTCH1_fw GCAGGTCGACACACTGGCGCACTATCCAG
Prom_PTCH1_rv ACGAGGATCCGCTCCGGTTGACAGACCA
PTCH1_WT mut
PTCH1_mBS1_fw GCCGGACCTGGCAGTATTTGCTGC
PTCH1_mBS1_rv CAAATACTGCCAGGTCCGGCTCGC
PTCH1_mBS2_fw GGTTGCCTACCTGCCTGGTCTCTCT
PTCH1_mBS2_rv AAGTAGAGAGACCAGGCAGGTAGGC
PTCH1_BS2-3T_fw CACACACTGGGTTGCCTACCTGGGTGATCTCTCTACTTTGGTGAGC
PTCH1_BS2-3T_rv GCTCACCAAAGTAGAGAGATCACCCAGGTAGGCAACCCAGTGTGTG
PTCH1_BS2-8A_fw CACACACTGGGTTGCCTACCTTGGTGGTCTCTCTACTTTGGTGAGC
PTCH1_BS2-8A_rv GCTCACCAAAGTAGAGAGACCACCAAGGTAGGCAACCCAGTGTGTG
PTCH1_VAR cloning
pGL3_PTCH1_vs_fw1 AATAGGCTGTCCCCAGTGC
pGL3_PTCH1_vs_rv1 TAGAATGCATGGTAGGCAACCCAGTG
pGL3_PTCH1_vs_fw2 ATTACTCGAGTCTCTACTTTGGTGAGCTG
pGL3_PTCH1_vs_rv2 GTCTTCCATGGTGGCTTTACC
Linker_fw TTTGAATTCCGGACCACCCAAC
Linker_rv TCGAGTTGGGTGGTCCGGAATTCAAATGCA
Inserted oligos*;
Cons_fw TTTAAGCTTCGTGGGTGGTCAC
Cons_rv TCGAGTGACCACCCACGAAGCTTAAATGCA
Gli1_Prom mut
GLI1_mBS_Cons_fw GTTTGCGCTTCTCGTGGGTGGTCCGGGCTTGCGGCCCGGCGG
GLI1_mBS_Cons_fw CCGCCGGGCCGCAAGCCCGGACCACCCACGAGAAGCGCAAAC
JUN_Prom mut
JUN_mBS3_Cons_fw CTTCGGAGTGTTCTCAACGTGGGTGGTCGACTCTCGGGAGACCGC
JUN_mBS3_Cons_rv GCGGTCTCCCGAGAGTCGACCACCCACGTTGAGAACACTCCGAAG
PTCH BS2 ChIP
ChIP_PTC_BS2_fwd GAGGATGCACACACTGGGTTGCCTA
ChIP_PTC_BS2_rev GGGCTGTCAGATGGCTTGGGTTTCT
TGM3 ChIP
ChIP_TGM3_BS1_fw AGAGGGGTGGGAGTGATTATC
ChIP_TGM3_BS1_rv AAGAAACGTCTCAGCAGAACC
ChIP_TGM3_B_fw AGGTCATTGAAAGGAGTGCCCG
ChIP_TGM3_B_rv ATGACTAAGAAAAGAGCAGAGGG
*Oligo for insertion of GLI consensus sequence (bold) into NsiI and XhoI restriction sites of the PTCH_Var promoter construct. Oligos containing all 27 GLI binding
site single substitutions were designed in the same way
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